Funding · Company
Capstan Therapeutics, Inc.
San Diego, CABiotech & Pharma
Capstan Therapeutics, Inc. of San Diego, CA has disclosed $227M across 3 Form D offerings filed with the SEC between Mar 20, 2024 and Mar 20, 2024.
$227M
Total disclosed
3
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$87M
Form D · Mar 20, 2024 ↗
Q1 2024
· target $175M
$76M
Form D · Mar 20, 2024 ↗
Q1 2024
· target $102M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0002015437Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →